HSBC Holdings’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
DC
HSBC Holdings's FLGT Position: Q2 2026 in Review
HSBC Holdings reduced its Fulgent Genetics (FLGT) stake by 31% in Q2 2026, selling an estimated $341K and leaving 45,048 shares worth $915K. The position accounts for ﹤0.01% of the portfolio, ranked #1994.
HSBC Holdings first reported a position in FLGT in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.79M in Q1 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.
- HSBC Holdings held 45,048 shares of Fulgent Genetics worth $915K as of Q2 2026.
- HSBC Holdings sold 20,126 Fulgent Genetics shares in Q2 2026, an estimated $341K.
- Fulgent Genetics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1994 holding.
- HSBC Holdings first reported a position in Fulgent Genetics in Q1 2021 and has held it in 18 quarters since.
- HSBC Holdings's Fulgent Genetics position peaked at $1.79M in Q1 2021.
- 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.